Clinical trial
The Practical Evidence of Antidiabetic Combination Therapy in Korea
NCT02231021
Study timeline
Study start (actual)2014-09-01Date precision: month
Registry last updated2019-02-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Interventions
alogliptinDRUG · verified · RxNorm: alogliptin
PioglitazoneDRUG · verified · RxNorm: pioglitazone
Sponsors & collaborators
Kun-Ho Yoonlead sponsor
Takedacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02231021 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.